Selexipag is a first-in-class oral treatment option to reduce progression and hospitalization for pulmonary arterial hypertension.
Lauren J. VanHook, PharmD
Advertisement
Lauren J. VanHook is a PGY-1 pharmacy resident at John Dempsey Hospital/UConn Health, Farmington, Conn.
Articles by Lauren J. VanHook, PharmD
Advertisement
Latest Updated Articles
- FDA approves PAH treatment
May 10th 2016
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves Utebzi as First Oral Carbapenem for Complicated UTIs
2
Heat and Pregnancy: What Pharmacists Need to Know
3
PBM Audits Target Pharmacies for Compliance, Revenue Recovery
4
Q&A: PBMs Use Audits to Generate Revenue Amid Unprecedented Scrutiny
5